Track the Orchestra BioMed Holdings, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on the US market, under the authority of SEC (Form 4). Market capitalisation: €316.2m. The latest transaction was disclosed on 28 August 2026 (Retenue fiscale). Among the most active insiders: Hochman David P. All data is free.
138
Insider Decl.
n/a
Thresholds
€2m
21 ops.
Buy Volume
€141,874
6 ops.
Sell Volume
33Σ signal
Buys €2m€141,874 Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
10,000 shares@ US$4.295.3% of flowCommon Stock, par value $0.0001 per share ("Common Stock")SEC:0001104659-26-028554:0
Canonical exit: 11 Jun 2026 (T+90)
25 of 138 declarations
About Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. is a company focused on developing innovative medical solutions. It specializes in creating medical devices for the treatment of cardiovascular diseases and other chronic conditions.